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Abstract In the present work we reported a semiquantitative detection of messenger ribonucleic acids (mRNAs) en-
coding the human heat shock proteins Hsp70-1, the stress inducible member of the HSP70 family, and hsp90a, the
inducible member of the HSP90 family. We investigated the change in the expression of these mRNAs in tissue
samples taken from the right atrium of 48 pediatric patients, soon after the ischemic period during surgery to correct
congenital heart diseases, in which a crystalloid cold cardioplegic solution was used. No significant variations were
found for either hsp70-1 or hsp90a expressions. Moreover, we searched for an association between the hsp70-1
promoter region polymorphism and the expression of the hsp70-1 in a smaller group of these patients (n 5 27). The
2110AA genotype was on average significantly associated with a decrease in the hsp70-1 mRNA level (P , 0.05),
whereas the other genotypes 2110AC or 2110CC did not seem to be associated with the hsp70-1 expression level.
The lack of any observed increase in the hsp70-1 expression level may be due to the high basal level of the Hsp70
protein in the tissues examined.
INTRODUCTION
In response to adverse environmental changes, cells
from many organisms increase the expression of a
large class of proteins known as heat shock or stress
proteins (Hsps), each named according to its molecular
weight (Benjamin and McMillan 1998). Numerous
studies have shown that synthesis of HSPs is enhanced
to protect cells against various stress conditions, such
as elevated temperature, exposure to heavy metals, as
well as ischemia (Knowlton et al 1991). Indeed, HSPs
act in protecting nascent or denaturated proteins from
aggregation, assisting their folding or refolding into the
correct conformation or their degradation after an ir-
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reversible damage, as well as in the translocation of
damaged proteins.
The induction of hsp70 gene expression by ischemia as
well as an inverse correlation between the gene expres-
sion of hsp70 and the infarct size have been previously
demonstrated in some animal models, as recently re-
viewed (Benjamin and McMillan 1998). In a preliminary
study, we investigated whether ischemic stress, induced
by cardiopulmonary bypass (CPBP), can affect the ex-
pression of hsp70-1 in the right atria of pediatric patients
undergoing surgery for congenital heart defect (CHD)
(Storti et al 2001). Our results showed no significant
changes in the hsp70-1 messenger ribonucleic acid
(mRNA) expression, the stress-inducible gene of the
HSP70 family, in atrial tissue after aortic cross-clamping
(CC).
To better clarify whether the Hsps could have a car-
dioprotective role during surgical stress, we also mea-
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sured the expression of hsp90a, the inducible member of
the HSP90 family, together with that of hsp70-1 in human
right atrium tissue samples, collected before and soon af-
ter the end of the aortic CC in 48 pediatric patients who
had undergone surgery for CHD. Furthermore, we
searched for an eventual association between the poly-
morphism of the hsp70-1 promoter region and the mRNA
expression level to explain the lack of expression varia-
tions in the hsp70-1 gene during cardiac surgery. For this
reason, we also genotyped 27 of these patients for this
polymorphism.
MATERIALS AND METHODS
Patients
We examined 48 pediatric patients (ages ranging from
3 months to 15 years) undergoing elective surgical cor-
rection of CHD, 25 being affected by tetralogy of Fallot
(TOF), 7 by ventricular septal defect (VSD), 1 by atrial
septal defect (ASD), 4 by atrioventricular canal defect
(AVCD), 4 by mitralic insufficiency (MI), 1 by double
outlet right ventricle (DORV), 2 by ASD 1 VSD, 3 by
aortic stenosis (AoSt), and 1 by anomalous partial pul-
monary venous return (APPVR). Before the surgical
procedure no patient was taking drugs nor was ex-
posed to maneuvers known to increase blood pressure.
CPBP was established with a crystalloid cold cardio-
plegic solution. During surgery, the mean CC temper-
ature was 28.158C 6 4.04 (average 6 standard devia-
tion). Mean CPBP time was 120 6 33 minutes and mean
CC time was 75 6 26 minutes. Patients were divided
into 4 groups according to their clinical condition and
the gravity of their disease. These groups are shown in
Table 1 along with the patients’ ages, diagnoses, CPBP
and CC times and temperatures, and pO2 (mmHg) at
the beginning of surgery under ventilation.
Two sequential samples were taken from a myocar-
dial site in the right atrium discarded during the sur-
gical intervention: the first specimen (right atrium 1
[RA1]) was obtained on average 20 minutes after the
sternotomy, before any surgical manipulation of the
heart. The second specimen (RA2) was obtained adja-
cent to the first one, outside the purse string, immedi-
ately after the end of the aortic CC. The duration of
anesthesia up to the time that the RA1 specimen was
taken as well as the total volume of the fluids admin-
istered to each patient are shown in Table 1 as a sur-
rogate marker of anesthesia and intraoperative stress.
The specimens were immediately frozen in liquid ni-
trogen and stored at 2808C until analysis.
Informed consent was obtained from parents because
all children were under 18 years of age, and the study
protocol was approved by the local Ethics Committee.
Semiquantitative reverse transcriptase–polymerase
chain reaction
Total RNA was extracted from each specimen by the Tri-
pure Isolation Reagent (Roche Molecular Biochemicals,
Mannheim, Germany) in a procedure based on the guan-
idinum thiocyanide method (Chomczynski and Sacchi
1987). The integrity of each RNA preparation was deter-
mined by electrophoretic fractionation through an aga-
rose-formaldehyde gel; 1 mg of RNA was treated with a
DNase RQ1 (Promega, Madison, WI, USA) and 300 ng
underwent reverse transcription by means of an oligo
(dT)12–18 priming (Gibco BRL Life Technologies, MD,
USA), in a mix containing also 2 mL of 53 Reverse Tran-
scriptase buffer (Promega), 0.5 mL of deoxynucleoside tri-
phosphates 1.25 mmol/L concentration of each, (Amer-
sham Pharmacia Biotech, Piscataway, NJ, USA), 5 U of
RNasin (Promega), and 20 U of Moloney Murine Leuke-
mia Virus (M-MLV RT) (Promega) and water up to a final
volume of 10 mL. Another contemporary reaction in
which no RT was added (No RT) was performed. The
complementary deoxyribonucleic acids (cDNA) of glyc-
eraldehyde 3 phosphate dehydrogenase (GAPDH) and
each hsp target were coamplified in a multiplex polymer-
ase chain reaction (PCR), using 2 couples of specific prim-
ers. Primer sequences are summarized in Table 2 (Tang
et al 1995). The PCR solution (final volume: 25 mL) con-
tained: 5 mL of the first strand cDNA solution, 1 mL of
1.25 mmol/L dNTP, 2.5 mL of 103 PCR buffer, 0.8 mL of
50 mmol/L magnesium chloride, 0.3 mmol/L of forward
and reverse GAPDH and hsp70-1 or hsp90a primers. The
annealing temperature was 588C for hsp70-1 and 638C for
hsp90a and 30 cycles were done in both cases. For each
sample, and for each target gene, 2 separate PCRs were
performed from the same RT. The PCR products were
resolved on a 6% polyacrylamide gel (19:1 acrylamide–
N,N-methyl-bis-acrylamide) stained by silver nitrate. The
densities of the GAPDH and hsp70-1 or hsp90a bands
were analyzed by the NIH Image 1.60 software (devel-
oped at the US National Institute of Health and available
on line at http://rsb.info.nih.gov/nih-image/). The cal-
culations were made as follows: first, the ratios between
the hsp70-1 or hsp90a and GAPDH band densities were
calculated; second, the variation of the hsp70-1 or hsp90a
expression in RA2, referred to as RA1 expression taken
as baseline, was evaluated for each sample and for the 2
different PCRs; third, the average of the 2 results was
calculated.
hsp70-1 Promoter polymorphism detection
DNA was extracted from myocardial tissue from 27 patients
by the Tripure Isolation Reagent (Roche Molecular Biochem-
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Table 1 Characterization of patients and changes in hsp70-1 and hsp 90a mRNA expression
Id Ages Sex Diagnosis
Disease
severity
Geno-
type
RA 2
hsp70-1
RA 2
hsp90a
CPBP
time
(min)
CC
time
(min)
CC
temp
(8C)
Anes-
thesia
dura-
tion (h)
VFI
(ml)
pO2(mmHg)
1
2
3
4
5
3m
6m
3y
9y
8m
F
M
F
F
M
ASD1VSD
ASD1VSD
MI
AVCD
TOF
II
II
II
II
IV
aa
cc
ac
0.6
0.7
0.2
2.4
0.3
no 90
1.7
1.4
2.5
0.6
106
116
163
95
135
48
69
113
60
75
27
24
24
26
20
5.5
4.5
6.6
4.2
5.0
190
490
900
1900
260
367
206
167
251
283
6
7
8
9
10
3y
14y
2y
2y
12y
M
F
F
F
M
TOF
MI
MI
TOF
TOF
IV
II
II
IV
III
aa
ab
ac
cc
aa
1.0
0.8
0.9
0.8
0.4
1.8
1.1
1.2
0.6
1.2
195
155
105
140
130
105
90
70
70
85
23
20
24
25
13
6.0
6.0
4.0
4.8
5.5
1330
2100
300
400
1100
75
66
525
43
168
11
12
13
14
15
10m
4y
11y
1y
1y
F
F
M
M
M
TOF
AoSt
TOF
TOF
TOF
IV
II
III
IV
IV
aa
cc
aa
aa
0.9
1.1
0.5
0.8
0.7
0.3
2.6
1.1
no 90
no 90
145
126
124
113
113
94
88
80
72
63
25
30
33
35
27
5.0
4.6
5.0
5.0
4.0
470
550
900
250
500
42
148
63
239
70
16
17
18
19
20
4m
3y
3y
7y
1y
F
M
M
F
F
AVCD
TOF
TOF
TOF
TOF
II
IV
IV
IV
III
aa
cc
ac
ac
ac
1.0
1.7
0.7
0.8
1.7
1.5
no 90
0.9
no 90
0.7
187
113
136
139
136
107
66
87
57
87
26
31
25
30
25
6.0
4.5
5.0
5.0
5.5
125
520
960
2000
880
157
71
33
130
47
21
22
23
24
25
7m
6m
6m
9m
4m
F
M
F
M
TOF
TOF
TOF
TOF
VSD
III
III
IV
IV
IV
aa
0.4
0.7
2.3
1.0
0.8
0.9
1.6
0.7
0.9
0.3
128
120
160
130
75
71
83
95
87
55
32
31
20
28
24
4.5
4.5
5.5
5.0
4.0
510
265
315
440
280
401
62
120
149
118
26
27
28
29
30
10m
2y
8m
3y
3y
M
M
F
M
M
TOF
TOF
TOF
DORV
VSD
III
III
III
IV
II
0.5
0.4
1.9
0.6
0.7
1.2
0.9
0.8
1.0
0.7
95
130
145
116
91
62
71
105
83
53
28
27
29
31
33
5.7
5.0
6.0
5.8
4.3
360
410
470
650
800
67
129
29
255
557
31
32
33
34
35
13y
3m
8m
7y
15y
F
F
M
M
M
TOF
VSD1PI
AVCD
AoSt
AoSt
III
II
II
II
IV
0.6
2.6
0.8
1.4
1.3
1.0
1.1
0.9
1.0
1.0
153
126
142
57
219
42
68
84
28
132
24
28
31
30
30
6.8
5.6
5.0
3.5
7.5
1500
460
800
3000
3400
117
287
180
318
328
36
37
38
39
40
11y
2y
2y
3y
3m
M
M
F
F
M
TOF
TOF
TOF
ASD
VSD
II
III
III
I
IV
cc
bc
1.3
1.6
2.6
0.8
1.2
0.76
1.1
1.0
1.5
1.2
129
124
161
46
143
69
73
87
13
105
20
20
32
31
31
5.8
5.7
5.0
3.7
6.0
1140
1220
830
350
300
76
49
48
203
215
41
42
43
44
45
3m
10m
9y
13y
7m
F
F
M
M
F
AVCD
VSD
APPVR
MI
TOF
III
II
II
II
IV
ac
bc
bc
ac
1.1
1
1.8
0.2
0.7
0.7
0.8
1.6
1.0
0.9
123
68
94
166
169
78
35
56
97
138
26
32
32
32
22
5.5
4.2
5.0
6.6
5.5
410
220
900
700
330
99
215
672
178
120
46
47
48
8m
2y
10m
M
F
F
TOF
VSD
VSD
III
II
II
ac
ac
ac
1.3
1.1
0.7
0.9
0.8
0.7
130
68
96
68
38
56
20
27
29
5.8
4.6
6.0
250
610
220
108
185
380
3m–15y average 1.07 1.01 125 75 28.15 5.2 754 175
st dev 0.59 0.41 35 26 4.04 0.84 696 142
y 5 years, m 5 months, TOF 5 Tetralogy of Fallot, DORV 5 Double Outlet Right Ventricle, AoSt 5 Aortic Stenosis, APPVR 5 Anomalous
Partial Pulmonary Return, ASD 5 Atrial Septal Defect, VSD 5 Ventricular Septal Defect, MI 5 Mitralic Insufficiency, AVCD 5 Atrioventricular
Canal Defect, genotype 5 hsp70-1 promoter region genotype; VFI, volume of intraoperatory fluid; h, hour, RA2 hsp70-1 5 changes in mRNA
hsp70-1 level, RA2 hsp90a 5 changes in mRNA hsp90a level.
icals). The genotyping protocol for the promoter region
polymorphism was taken from Cascino (Cascino et al 1993,
Table 2), with some modifications. Briefly, 50 ng of DNA
was amplified with 10 mol/L of each specific primer in 25
mL of total reaction volume, with an annealing temperature
of 558C. Five microliters of PCR product was loaded on a
10% polyacrylamide (29% acrylamide, 1% bis-acrylamide in
Tris Boric EDTA-TBE-buffer (TBE buffer) gel vertical plate
20 cm in length, run at room temperature for 22 hours, at
18 mA in TBE buffer 13, and then stained by silver nitrate.
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Table 2 Primer sequences and polymerase chain reaction product size
Gene
Primer sequences
Primer F Primer R
Product
size (bp)
hsp90a
hsp70-1
GAPDH
hsp70-1 Promoter polymorphism
ACAAGCACATATGGCTGGACAGCA
CTAGCCTGAGGACTGGCTGCGACA
GAGTCAACGGATTTGGTCGT
CGCCATGGAGACCAACACCC
TTCAGTTACAGCAGCACTGGTATC
GTTCCCTGCTCTCTGTCGGCTCGG
GGTGCCATGGAATTTGCCAT
GCGGATCCGCGGTTCCCTGCTCTC
342
205
156
496
RESULTS
DNase 1 treatment
DNase 1 treatment is usually done after total RNA ex-
traction to assure that no genomic DNA is contaminating
the RNA solution (Grillo and Margolis 1990). In the ab-
sence of genomic DNA contamination, the cDNA synthe-
sis reactions, performed without RT (No RT), and the sub-
sequent PCR gave no products (data not shown).
Expression of hsp70-1
The results of hsp70-1 expression changes in the RA2 bi-
opsy, compared with the mRNA expression in the RA1
biopsy considered as baseline in all 48 pediatric patients,
are shown in Table 1. On average, no change in the
mRNA level was found in hsp70-1 expression (1.07- 6
0.59-fold the RA1 baseline value). No relationship be-
tween changes in the hsp70-1 expression and patient age
distribution, disease severity classes, or CPBP duration
was found (Figs 1A, 2A, and 3A). Furthermore, no sig-
nificant correlation was found between the expression
changes and the CPBP time (R2 5 0.001, P 5 0.8201) or
CC time (R2 5 0.0001, P 5 0.9435) or temperature (R2 5
0.004, P 5 0.6886).
Expression of hsp90a
The results of the measurement of hsp90a mRNA expres-
sion in the 48 patients are shown in Table 1. On average,
no variation in the mRNA level was found in hsp90a ex-
pression when the values obtained after the aortic CC
were compared with those measured before CC (1.01- 6
0.41-fold the RA1 baseline value). No relationship was
found between changes in hsp90a expression and patient
age distribution, disease severity classes or CPBP dura-
tion (Figs 1B, 2B, and 3B). No significant correlation was
found between the expression changes of hsp90a mRNA
and the CPBP time (R2 5 0.001, P 5 0.8680) or the CC
time (R2 5 0.001, P 5 0.8146) or temperature (R2 5 0.025,
P 5 0.3130).
Analysis of the hsp70-1 promoter region polymorphism
Using the primers described by Cascino (Cascino et al
1993), a single 496–base pair product was obtained. On
the polyacrylamide gel, 3 bands of different mobility were
interpreted as corresponding to different alleles and were
named: a (slow), b (fast), c (intermediate). Variations
among the 3 alleles were restricted to 2 sites: 2110 and
1120. At 2110 the a allele differed from b and c for the
presence of an adenine instead of a cytosine. At 1120 the
b allele differed from a and c for the presence of a cyto-
sine instead of a thymine.
Twenty-seven patients were analyzed for this poly-
morphism, and the results are shown in Table 1. Indi-
viduals could exhibit either 1 or 2 bands; the combi-
nations found were the following: ‘‘ab’’ (2110AC,
1120TC) (1/27, fab 5 0.037), ‘‘ac’’ (2110AC, 1120TT)
(10/27 fac 5 0.370), ‘‘bc’’ (2110CC, 1120CT) (3/27 fbc
5 0.111), ‘‘aa’’ (2110AA, 1120TT) (8/27 faa 5 0.296),
and ‘‘cc’’ (2110CC, 1120TT) (5/27 fcc 5 0.185). The
‘‘bb’’ (2110CC, 1120CC) genotype has not been en-
countered, as previously reported by Cascino (Cascino
et al 1993). The genotype assortment was as expected
from the Hardy-Weinberg equilibrium in the 3 allelic
system; the calculated frequencies of the 3 alleles being
as follows: fa 5 0.500, fb 5 0.074, and fc 5 0.426.
Relation between hsp70-1 promoter genotype and
hsp70-1 mRNA expression
The ‘‘aa’’ genotype, found in 8 patients (3, 6, 10, 11, 14,
15, 16, 22), showed on average a significant decrease in
the hsp70-1 mRNA level after the ischemic period (on av-
erage 0.71 6 0.29, t-test P-value 5 0.025, Table 1). More-
over, the only patient whose genotype was ‘‘ab’’ showed
a decrease in the hsp70-1 mRNA level, whereas the other
patients, characterized as ‘‘ac,’’ ‘‘bc,’’ or ‘‘cc,’’ had no sig-
nificant changes of hsp70-1 mRNA expression before and
after the ischemic period. Data from genotypic analysis
are presented in Figure 4.
DISCUSSION
In our study we evaluated the change in hsp70-1 mRNA
expression in biopsies from right atria of pediatric pa-
tients undergoing surgery for CHD correction. During
surgery, CPBP was established by means of a cold crys-
talloid cardioplegic solution. Because of the young age of
the patients, the samples collected were very small (8–20
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Fig 1. Age distribution: relationship
between age distribution of patients
and changes and hsp70-1 (A) or
hsp90a (B) expression.
mg). Consequently, a previously described semiquantita-
tive method of quantifying mRNA expression from only
300 ng of total RNA (Storti et al 2001) was set up using
the housekeeping GAPDH gene as an internal standard,
on the assumption that its level would remain unchanged
before and after the ischemic period. Before reverse-tran-
scription, total RNA was treated with a DNase 1 and a
No RT control was included (Grillo and Margolis 1990).
The DNase I pretreatment is essential because hsp70-1 is
an intronless gene (Wu et al 1985) and also because in
genomic DNA there is a GAPDH pseudogene. Indeed,
DNase I pretreatment eliminates the false positives that
can result from any preexisting DNA and could confuse
the interpretation of results.
In our study, on average no variation of hsp70-1 mRNA
expression was found after the ischemic period (1.07- 6
0.59-fold the baseline value). However, a limitation of this
study is that it has not been possible to have a truly base-
line cardiac preparation with which to compare the in-
traoperative surgical samples because the samples were
taken from individuals who had severe cardiac disease
and who often experienced varying degrees of patho-
physiologic stresses before surgery. In fact, the first sam-
ple represents a time point in which a patient has under-
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Fig 2. Disease severity classes: re-
lationship between the severity of pa-
tient disease , classified from I to IV ac-
cording to the minor or major gravity of
the congenital heart disease, and
changes in hsp70-1 (A) or hsp90a (B)
expression.
gone an open sternotomy and this initial sample may re-
flect a significant degree of stress already experienced by
the patient. However, this protocol of study was the best
we could set up because it was not possible to obtain a
completely unstressed human cardiac preparation to use
as baseline.
In our opinion, among the hypotheses that could ex-
plain our result, 2 appear very interesting.
A first consideration may be done about the basal
high level of the Hsp70 protein (Shi et al 1998) in pa-
tients before cardiosurgery. In fact, it has been noted
that in higher eukaryotes, the stress signal leads to the
elevated expression of heat shock genes; stress induced
transcription requires activation of heat shock factors
(HSFs) that bind to the heat shock promoter element.
In unstressed cells, HSFs are maintained in an inert
non–DNA-binding state. Upon exposure of cells to
stress conditions, HSFs become activated to a DNA-
binding, transcriptionally active state, which results in
the preferential transcription of the heat shock genes.
In stress conditions, Hsp70 stably associates with the
heat shock factor 1 (HSF1), and so it functions as a re-
pressor of transcriptional activity of the heat shock
genes (Shi et al 1998). According to this hypothesis, a
preexisting state of physiological stress, perhaps due in
our patients to the congenital heart disease, can pro-
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Fig 3. Cardiopulmonary bypass
(CPBP) duration. Relationship between
the duration of CPBP and changes and
hsp70-1 (A) or hsp90a (B) expression.
voke an inhibition of the further transcription of all
heat shock genes. In the present study, this hypothesis
has been tested by the evaluation of the change in the
expression of hsp90a, the inducible member of the
HSP90 family. It has been shown, in fact, that in hsp70
overexpressing cells the transcription of the hsp90a
gene was not induced after heat shock, whereas in cells
uninduced for hsp70 there was a dramatic heat shock
induction of the hsp90a gene transcription (Shi et al
1998). We found on average no induction of hsp90a
mRNA too (1.01- 6 0.41-fold the baseline value). In
conclusion, we can suggest that a negative feedback
regulation by Hsp70 acting as an expression repressor
on hsp genes transcription is possible.
A second hypothesis involves the hsp70-1 promoter re-
gion polymorphism. The method used for detecting the
promoter polymorphism yields stereoscopic images of
the DNA superhelical conformation, which can be direct-
ly related to the electrophoretic behavior. In effect, the
introduction of an adenine at position 2110 (ie, allele a)
increases the curvature of the molecule and provides an
adequate explanation of the electrophoretic retardation of
this allele; the modification of the DNA curvature by in-
troducing a cytosine at the 1120 site (allele b) is much
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Fig 4. hsp70-1 Promoter region poly-
morphism. Relationship between the
mean change of mRNA hsp70-1 for
each observed genotype.
less marked. Moreover, the adenine-cytosine interchange
at position 2110, which gives the strongest effect on DNA
curvature, is located between the first 2 of a series of 5
consecutive regulatory elements involved in the binding
of HSF1 (Cascino et al 1993). It is possible that this inter-
change causes a variation of hsp70-1 expression after
stress stimuli, owing to the intimate connection between
the local curvature of a DNA segment and its function in
regulatory processes. Indeed, our data indicate that the
2110AA genotype seems to be significantly associated
with an inactivation of the hsp70-1 expression, whereas
the other genotypes do not seem to be associated with
the hsp70-1 mRNA level. Unfortunately, we obtained the
genotype data only from a minority of patients; our re-
sult, although suggestive, needs to be confirmed in a larg-
er population, and so further studies are necessary to bet-
ter clarify the pathophysiological importance of this as-
sociation.
In conclusion, on average, no increase in the hsp70-1
mRNA expression was found in biopsies from human
right atria taken soon after the ischemic period during
heart surgery in the present study. It is possible that
the lack of any observed increase in hsp70-1 expression
may be due to the high basal level of Hsp70 protein
because hsp90 failed to induce in the same tissue. Fur-
thermore, our data revealed an association between the
hsp70-1 promoter polymorphism and the expression of
the hsp70-1: in fact, the 2110AA genotype seems to be
significantly associated with an inactivation of the hsp
transcription.
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